Results 71 to 80 of about 11,371 (259)
A possible role of GDNF expression by which cabergoline use affects corpus callosum
Journal of Pediatric and Neonatal Individualized Medicine, 2018 A variety of malformations have been associated with cabergoline use during gestation. Recently we had a preterm male infant referred to our Neonatal Intensive Care Unit diagnosed with corpus callosum agenesis confirmed by brain ultrasound and brain ...
Georgios Mitsiakos, Anastasia Gkampeta
doaj +1 more source
Clinical Case Reports, Volume 13, Issue 7, July 2025.ABSTRACT Syringomyelia has several possible causes, commonly including Chiari malformation, spinal cord tumors and injuries, and damage caused by lesions around the spinal cord. A 34‐year‐old female was diagnosed with primary breast cancer and vertebral metastasis and was initiated on an extensive regimen of chemotherapy and radiotherapy.
Ahmed Reda Abdelhalim +3 more
wiley +1 more source
The Effectiveness of Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome [PDF]
Iranian Journal of Medical Sciences, 2011 Type 2 receptors for vascular endothelial growth factor are believed to be involved in the pathophysiology of ovarian hyperstimulation syndrome (OHSS).
Marzieh Agha Hosseini +4 more
doaj
Avicenna Journal of Medicine, 2015 Background: Ovarian hyperstimulation syndrome (OHSS) is the most serious and potentially life-threatening iatrogenic complication associated with ovarian stimulation during assisted reproductive technology protocols. The aim of this study was to evaluate
Niyazi Kilic +5 more
doaj +1 more source
Acromegaly: pathogenesis & treatment [PDF]
, 2019 Acromegaly is a multi-system disorder whose etiology is most often traced back to a growth hormone-secreting pituitary adenoma (PA). Growth hormone (GH) secretion promotes insulin-like growth factor 1 (IGF-1) release from peripheral tissues, leading to ...
Tilvawala, Megha
core
Place of Cabergoline in Acromegaly: A Meta-Analysis [PDF]
The Journal of Clinical Endocrinology & Metabolism, 2011 Context: Cabergoline is widely considered to be poorly effective in acromegaly. Objective: The aim of this study was to obtain a more accurate picture of the efficacy of cabergoline in acromegaly, both alone and in combination with somatostatin ...
Philippe Chanson +2 more
openaire +3 more sources
Progress on the development of Class A GPCR‐biased ligands
British Journal of Pharmacology, Volume 182, Issue 14, Page 3249-3300, July 2025.Class A G protein‐coupled receptors (GPCRs) continue to garner interest for their essential roles in cell signalling and their importance as drug targets. Although numerous drugs in the clinic target these receptors, over 60% GPCRs remain unexploited. Moreover, the adverse effects triggered by the available unbiased GPCR modulators, limit their use and
Paula Morales +20 more
wiley +1 more source
Journal of Pharmacological Sciences, 2006 .: Cabergoline is used in the treatment of Parkinson’s disease (PD). Clarithromycin is a potent inhibitor of CYP3A4 and P-glycoprotein and is often co-administered with cabergoline in usual clinical practice.
Akiko Nakatsuka +7 more
doaj
Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy
ESC Heart Failure, 2023 Aims Peripartum cardiomyopathy (PPCM) is a rare heart disease, occurring in previously heart‐healthy women during the last month of pregnancy or the first months after delivery due to left ventricular (LV) systolic dysfunction.
Tobias J. Pfeffer +12 more
doaj +1 more source
Case report: Bilateral simple Syndactyly in a toddler with maternal exposure to cabergoline
Clinical Case Reports, 2022 Cabergoline is routinely prescribed in the management of prolactin excreting adenomas and is associated with low risk of congenital malformations and teratogenicity.
Shima Afshar +4 more
doaj +1 more source